Search

everythinglearnresearchcommunity

for

Search:↓

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Targeting CD169+ skin macrophages may help treat psoriasis.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

TLR3 activation helps improve skin and hair follicle healing in mice.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.